CClinicalTrials.gg
RecruitingNCT07413302Updated Feb 17, 2026

Investigation of Preoperative Factors Influencing the Outcome of Motor Deficits in Patients Undergoing Lumbar Microdiskectomy

An observational study in Motor Deficits, Lumbar Discectomy and Muscle Weakness, sponsored by Aristotle University Of Thessaloniki. Recruiting at 3 sites in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Aristotle University Of Thessaloniki · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

Lumbar disc herniations may result in lower limb weakness. In such cases, there is a strong indication for surgical intervention through microdiscectomy. This clinical study aims to investigate preoperative factors that may influence the postoperative outcomes of patients undergoing this procedure.

Read the detailed description

Background: Motor deficits owing to neural compression caused by lumbar disc herniation are a common problem encountered in spine surgery. Microdiscectomy is considered the preferred procedure for the treatment of limb paresis related to a herniated disc. Nevertheless, there is a restricted number of clinical studies in the literature investigating the role of preoperative factors that could influence the postoperative outcome in these patients.

Aim: To investigate the prognostic factors determining the outcome in patients with lower limb paresis caused by a herniated lumbar disc subjected to microdiscektomy.

Study type: Primary clinical research, observational prognostic study. Materials: Patients suffering from a motor deficit due to lumbar disc herniation to undergo lumbar microdiscectomy in three neurosurgical departments.

Protocol: Prospective multicenter study. This research will discover the prognostic value of two primary and five secondary preoperative factors. Primary factors: a) the severity of paresis, b) the duration of paresis. Secondary factors: a) age, b) body mass index, c) diabetes mellitus, d) anatomic location of the herniated disc, e) morphology of the herniated disc.

Outcomes: The key evaluation criterion is the muscle strength of the most severely affected lower limb muscle according to the six-point (0-5) Medical Research Counsil (MRC) Scale for Muscle Strength. After the comparison between the postoperative and preoperative muscle strength, the outcome of paresis will be recorded as: a) full recovery, b) partial recovery or c) no recovery.

Sample size: Forty (40) patients.

02

Conditions studied

  • Motor Deficits
  • Lumbar Discectomy
  • Muscle Weakness
  • Paresis
  • Lumbar Disc Herniation

Keywords

  • microdiscectomy
  • lumbar disc herniation
  • motor deficit
  • lower limb paresis
  • prognostic factors microdiscectomy
  • disc herniation outcome
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients visiting the three recruitment hospitals, all located in North Greece.

Inclusion criteria

  • Patients suffering from lower limb paresis (motor deficit) caused by lumbar disk herniation undergoing a single-level microdiskectomy
  • Age (years) > 17

Exclusion criteria

Exclusion Criteria:

  • Age (years) \< 18
  • Medical history of lumbar spine surgery
  • Absence of limb paresis
  • Motor deficit caused by other than disk herniation aetiologies
  • Reoperation within 6 months after microdiskectomy
  • Microdiskectomy at more than one level
  • Cauda equina syndrome
  • Peripheral neuropathy
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Patients with limb paresis due to lumbar disk herniation undergoing microdiskectomy

    Patients suffering from motor deficit because of lumbar disk herniation scheduled to undergo single-level microdiskectomy.

05

What researchers measure

Primary outcomes

  1. Muscle Strength

    The strength of lower main muscles will be assessed and will be rated according to the Medical Research Council Scale for Muscle Strength. The scale takes values between 0 and 5, with 5 being the best possible (healthy).

    Time frame: Perioperative

  2. Duration of paresis before surgical treatment

    Time between the initiation of paresis and surgical treatment measured in days

    Time frame: Baseline

Secondary outcomes

  1. Age

    The age of participant as measured in years

    Time frame: Baseline

  2. Obesity

    Body Mass Index (BMI) measured as the ratio between the mass measured in kilograms over the square of height measured in meters. There will be two groups of patients: a) with obesity and b) without obesity.

    Time frame: Baseline

  3. Diabetes Melitus

    Participant is diagnosed with diabetes melitus (yes/no)

    Time frame: Baseline

  4. Hernia location

    Categorisation of hernia location based on Magnetic Resonance Imaging (MRI) to a) central, b) subarticular, c) foraminal, and d) extra-foraminal.

    Time frame: Baseline

  5. Hernia morphology

    Hernia morphology will be categorised based on radiology images to a) central, b) extrusion and c) sequestation.

    Time frame: Baseline

  6. Level of Pain

    The pain level of participants will be measured using the Numeric Rating Scale for Pain which ranges from 0 (no pain) to 10 (worst pain imaginable).

    Time frame: Perioperative

  7. Functionality

    The functionality of participants will be measured using the Oswestry Disability Index (ODI) which consists of 10 questions using a 5-level Likert scale with 0 being the best.

    Time frame: Perioperative

  8. Quality of life assessment

    This outcome will be measured using the EQ-5D-5L questionnaire. It is using 5-Level Likert scale, with 0 being the best. Also, it includes a self-report of health status using a 0 to 100 scale, 100 being best.

    Time frame: Perioperative

06

Study locations

3 of 3 sites recruiting
  • General Hospital of Kavala
    Kavala, 65500, Greece
    • Eva Kanelli · Contact · pk@kavalahospital.gr · +302513501545
    • Panagiotis Sarlis, MSc, MD · Principal investigator
    • Stavros Stamatiou · Sub investigator
    • Georgios Kalostos · Sub investigator
    Recruiting
  • Hippokration General Hospital
    Thessaloniki, 54642, Greece
    • Dimitra Emmanouilidou · Contact · qre@ippokratio.gr · +302313312690
    • Ioannis Magras, Professor · Principal investigator
    • Parmenion Tsitsopoulos, Professor · Sub investigator
    • Elias Antoniades · Sub investigator
    • Emmanouil Kenanoglou · Sub investigator
    • Panagiotis Kartsidis · Sub investigator
    Recruiting
  • European Interbalkan Medical Center
    Thessaloniki, 57001, Greece
    • Olymbia Semoglou · Contact · scientific.director@interbalkan-hosp.gr · +302310400342
    • Alkinoos Athanasiou · Principal investigator
    • Georgios Psychidis · Sub investigator
    • Georgios Antonoglou · Sub investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07413302
Lead sponsor
Aristotle University Of Thessaloniki
Collaborators
Hippocration General Hospital, General Hospital of Kavala, European Interbalkan Medical Center
Responsible party
Sponsor
First posted
Feb 17, 2026
Start date
Jul 3, 2024
Primary completion
Jun 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Panagiotis Sarlis
Contact
psarlis@gapps.auth.gr
+302513501449
Panagiotis Sarlis
principal investigator · Aristotle University Of Thessaloniki

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion